Harnessing multi-source data for individualized care in Hodgkin Lymphoma.

Area of Science:

• Hematology
• Oncology
• Data Science

Background:

• Hodgkin lymphoma is a curable cancer primarily affecting young adults.
• Treatment consensus remains elusive, with ongoing debate regarding radiation therapy and evolving novel therapeutics.
• Varied long-term risks exist across different treatment approaches.

Purpose of the Study:

• To develop clinical decision models for Hodgkin lymphoma using individual patient data.
• To guide healthcare providers, patients, and caregivers in treatment decision-making.
• To estimate risks of late effects from cumulative treatment exposure.

Main Methods:

• Established the HoLISTIC Consortium in 2018, integrating disease and methods experts.
• Created a master database of individual patient data from the past 20 years using data science principles.
• Employed clinical prediction tools, multi-state models, and simulation modeling for decision-making and risk assessment.

Main Results:

• A comprehensive master database of Hodgkin lymphoma patient data has been compiled.
• Methodological approaches for clinical decision-making, including prediction and multi-state models, have been developed.
• Simulation modeling is utilized to estimate late effects based on treatment history.

Conclusions:

• The developed database and clinical decision tools offer a dynamic approach to managing Hodgkin lymphoma.
• These resources are expected to evolve with new data, improving personalized treatment strategies.
• The HoLISTIC Consortium's work facilitates informed decision-making for improved patient care and outcomes.